Acute Migraine Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Acute Migraine Drugs Market was valued at USD 1.29 billion in 2020 and is expected to reach USD 3.51 billion by the year 2028, at a CAGR of 13%. 

Migraine is a neurological disorder that includes headaches, nausea, impaired sense of smell, increased sensitivity to sound and light, and numbness. These headaches occur on one side of the head of different duration and intensity. The acute migraine drug market includes ergot alkaloids, triptans, and others that are offered to end migraine attacks. Growing awareness related to the types of migraine headaches and the different treatment options available is propelling the growth of this market. This market is witnessing changes in terms of new treatments and powerful medical research.

Market Segments

By Treatment Type:

• Abortive Treatment
• PreventiveTreatment 
   

By Drug Type:

• Triptans
• Ergot Alkaloids
• NSAIDs
• Acetylcholine Inhibitors/ Neurotoxins
• Ditans
• CGRP mAbs
• Others

Key Players

Some of the key players being Abbott Laboratories, Allergan Plc (Abbvie Inc.), Amgen Inc., AstraZeneca Plc, Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), Eisai Co. Ltd., Eli Lilly and Company, Endo International Plc, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Sanofi SA and Teva Pharmaceutical Industries Limited.

Scope of the Report

The research study analyzes the global Acute Migraine Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Acute Migraine Drugs Market Report

1. What was the Acute Migraine Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Acute Migraine Drugs Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Acute Migraine Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.